Japan Price Reforms - Major Takeaways
Executive Summary
Japan's complex reimbursement pricing system was further tweaked in April in a bid to raise the bar for innovation while controlling costs. What are the main changes and is industry happy?
You may also be interested in...
Lupin Hit By US Settlement, Japan Injectables Selloff
Despite 10% revenue growth, Lupin ended up with a second-quarter loss from a one-time charge from settling a US lawsuit and the sale of its Japan injectables business. The firm is now counting on levothyroxine and secnidazole to carry it through the next few quarters, amid speculation that it might divest its Japanese subsidiary.
Lupin Q2 Hit By US Settlement, Japan Injectables Selloff
Despite 10% revenue growth, Lupin ends up with a second-quarter loss from a one-time charge from settling a US lawsuit and the sale of its Japan injectables business. It's now counting on levothyroxine and secnidazole to carry it through the next few quarters, amid speculation that it might divest its Japanese subsidiary.
Scrip’s Top Five Stories Of 2018
A look back at the Scrip stories that piqued the most interest for our readers in 2018.